FLULAVAL 2026/2027
influenza virus vaccine
Listed by ID Biomedical Corporation of Quebec
- Strength
- 15 ug/.5mL, 15 ug/.5mL, 15 ug/.5mL
- Form
- Suspension
- Route
- Intramuscular
What it contains
- Influenza A Virus A/switzerland/6849/2025 Ivr 278 (h1n1) Antigen (uv, Formaldehyde Inactivated) 15 ug/.5mL
- Influenza A Virus A/michigan/105/2025 San 049a (h3n2) Antigen (uv, Formaldehyde Inactivated) 15 ug/.5mL
- Influenza B Virus B/tokyo/eis13-175/2025 Antigen (uv, Formaldehyde Inactivated) 15 ug/.5mL
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
FDA record
| Dosage form | Suspension |
|---|---|
| Route | Intramuscular |
| Approval route | BLA — biologic licence |
| NDC code | 19515-822 |
| FDA application | BLA125163 |
| Package sizes listed | 1 |
| Marketed since | July 2026 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.